Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and manifolds.
In these days of reducing, reusing and recycling, it may seem strange that anyone would be going out of their way to make a potentially reusable product disposable. It all makes sense, however, when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results